At the time of writing, CAMP4 Therapeutics Corp [CAMP] stock is trading at $2.78, down -0.36%. An important factor to consider is whether the stock is rising or falling in short-term value. The CAMP shares have gain 87.84% over the last week, with a monthly amount glided 101.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
CAMP4 Therapeutics Corp [NASDAQ: CAMP] stock has seen the most recent analyst activity on May 27, 2025, when Wedbush initiated its Outperform rating and assigned the stock a price target of $8. On November 05, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $18 on the stock. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $23 on November 05, 2024.
For the past year, the stock price of CAMP4 Therapeutics Corp fluctuated between $1.30 and $12.30. Currently, Wall Street analysts expect the stock to reach $12.5 within the next 12 months. CAMP4 Therapeutics Corp [NASDAQ: CAMP] shares were valued at $2.78 at the most recent close of the market. An investor can expect a potential return of 349.64% based on the average CAMP price forecast.
Analyzing the CAMP fundamentals
Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -17.85%, Pretax Profit Margin comes in at -17.22%, and Net Profit Margin reading is -17.22%. To continue investigating profitability, this company’s Return on Assets is posted at -1.01, Equity is -1.31 and Total Capital is -1.22. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.54 points at the first support level, and at 2.29 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.99, and for the 2nd resistance point, it is at 3.19.
Ratios To Look Out For
It is important to note that CAMP4 Therapeutics Corp [NASDAQ:CAMP] has a current ratio of 5.60. On the other hand, the Quick Ratio is 5.60, and the Cash Ratio is 5.32. Considering the valuation of this stock, the price to sales ratio is 18.62, the price to book ratio is 1.40.
Transactions by insiders
Recent insider trading involved Polaris Management Co. VII, L., 10% Owner, that happened on Sep 11 ’25 when 1.31 million shares were purchased. Director, Nashat Amir completed a deal on Sep 11 ’25 to buy 1.31 million shares. Meanwhile, Chief Medical Officer Maricich Yuri bought 6060.0 shares on Sep 11 ’25.
